Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity
Authorized Users Only
2019
Authors
Seke, Mariana
Petrović, Danijela
Labudović-Borović, Milica

Borisev, Ivana
Novaković, Mirjana M.

Rakočević, Zlatko Lj.

Đorđević, Aleksandar N.

Article (Published version)

© 2019, Springer Nature B.V.
Metadata
Show full item recordAbstract
Fullerenol C60(OH)24 with its spherical shape, symmetrical structure, 1 nm size and the ability to form polyionic nanoparticles in water solution, was used to synthesise a novel nanocomposite made of fullerenol nanoparticles (FNP) and iron ions (Fe2+). The FNP/Fe2+ nanocomposite was characterised by DLS and TEM-EDS analyses which have shown that the size distribution of FNP/Fe2+ stayed in the same scope as the size distribution of FNP, ranging from 11 to 60 nm. However, Fe2+ did affect the change of FNP’s zeta potential (− 49.2 mV), shifting it to more positive values (− 30.8 mV). In this study, it was assumed that FNP/Fe2+ could reduce the toxic effects of doxorubicin (Dox). Male Wistar rats were treated i.p. with FNP/Fe2+ nanocomposite 1 h prior to Dox treatment. At the subcellular level, the ultrastructural analysis revealed minor alterations sporadically displayed within the heart and liver tissues. Moreover, at the molecular level, the gene expressions analysis of mRNAs for catala...se (heart and liver) and MnSOD (only liver) were significantly downregulated, indicating reduction in oxidative stress. Overall, the pretreatment with FNP/Fe2+ nanocomposite, followed by Dox application, significantly diminished harmful effects of the applied drug on the heart and liver, suggesting the potential protective effect of the nanocomposite on the healthy tissues. © 2019, Springer Nature B.V.
Keywords:
Fullerenol / Iron / Doxorubicin / Nanocomposite / qRTR-PCR / Ultrastructural analysis / Nanomedicine / Health effectsSource:
Journal of Nanoparticle Research, 2019, 21, 11, 239-Funding / projects:
DOI: 10.1007/s11051-019-4681-4
ISSN: 1388-0764
WoS: 000497401900002
Scopus: 2-s2.0-85075100010
Collections
Institution/Community
VinčaTY - JOUR AU - Seke, Mariana AU - Petrović, Danijela AU - Labudović-Borović, Milica AU - Borisev, Ivana AU - Novaković, Mirjana M. AU - Rakočević, Zlatko Lj. AU - Đorđević, Aleksandar N. PY - 2019 UR - https://vinar.vin.bg.ac.rs/handle/123456789/8649 AB - Fullerenol C60(OH)24 with its spherical shape, symmetrical structure, 1 nm size and the ability to form polyionic nanoparticles in water solution, was used to synthesise a novel nanocomposite made of fullerenol nanoparticles (FNP) and iron ions (Fe2+). The FNP/Fe2+ nanocomposite was characterised by DLS and TEM-EDS analyses which have shown that the size distribution of FNP/Fe2+ stayed in the same scope as the size distribution of FNP, ranging from 11 to 60 nm. However, Fe2+ did affect the change of FNP’s zeta potential (− 49.2 mV), shifting it to more positive values (− 30.8 mV). In this study, it was assumed that FNP/Fe2+ could reduce the toxic effects of doxorubicin (Dox). Male Wistar rats were treated i.p. with FNP/Fe2+ nanocomposite 1 h prior to Dox treatment. At the subcellular level, the ultrastructural analysis revealed minor alterations sporadically displayed within the heart and liver tissues. Moreover, at the molecular level, the gene expressions analysis of mRNAs for catalase (heart and liver) and MnSOD (only liver) were significantly downregulated, indicating reduction in oxidative stress. Overall, the pretreatment with FNP/Fe2+ nanocomposite, followed by Dox application, significantly diminished harmful effects of the applied drug on the heart and liver, suggesting the potential protective effect of the nanocomposite on the healthy tissues. © 2019, Springer Nature B.V. T2 - Journal of Nanoparticle Research T1 - Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity VL - 21 IS - 11 SP - 239 DO - 10.1007/s11051-019-4681-4 ER -
@article{ author = "Seke, Mariana and Petrović, Danijela and Labudović-Borović, Milica and Borisev, Ivana and Novaković, Mirjana M. and Rakočević, Zlatko Lj. and Đorđević, Aleksandar N.", year = "2019", abstract = "Fullerenol C60(OH)24 with its spherical shape, symmetrical structure, 1 nm size and the ability to form polyionic nanoparticles in water solution, was used to synthesise a novel nanocomposite made of fullerenol nanoparticles (FNP) and iron ions (Fe2+). The FNP/Fe2+ nanocomposite was characterised by DLS and TEM-EDS analyses which have shown that the size distribution of FNP/Fe2+ stayed in the same scope as the size distribution of FNP, ranging from 11 to 60 nm. However, Fe2+ did affect the change of FNP’s zeta potential (− 49.2 mV), shifting it to more positive values (− 30.8 mV). In this study, it was assumed that FNP/Fe2+ could reduce the toxic effects of doxorubicin (Dox). Male Wistar rats were treated i.p. with FNP/Fe2+ nanocomposite 1 h prior to Dox treatment. At the subcellular level, the ultrastructural analysis revealed minor alterations sporadically displayed within the heart and liver tissues. Moreover, at the molecular level, the gene expressions analysis of mRNAs for catalase (heart and liver) and MnSOD (only liver) were significantly downregulated, indicating reduction in oxidative stress. Overall, the pretreatment with FNP/Fe2+ nanocomposite, followed by Dox application, significantly diminished harmful effects of the applied drug on the heart and liver, suggesting the potential protective effect of the nanocomposite on the healthy tissues. © 2019, Springer Nature B.V.", journal = "Journal of Nanoparticle Research", title = "Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity", volume = "21", number = "11", pages = "239", doi = "10.1007/s11051-019-4681-4" }
Seke, M., Petrović, D., Labudović-Borović, M., Borisev, I., Novaković, M. M., Rakočević, Z. Lj.,& Đorđević, A. N.. (2019). Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity. in Journal of Nanoparticle Research, 21(11), 239. https://doi.org/10.1007/s11051-019-4681-4
Seke M, Petrović D, Labudović-Borović M, Borisev I, Novaković MM, Rakočević ZL, Đorđević AN. Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity. in Journal of Nanoparticle Research. 2019;21(11):239. doi:10.1007/s11051-019-4681-4 .
Seke, Mariana, Petrović, Danijela, Labudović-Borović, Milica, Borisev, Ivana, Novaković, Mirjana M., Rakočević, Zlatko Lj., Đorđević, Aleksandar N., "Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity" in Journal of Nanoparticle Research, 21, no. 11 (2019):239, https://doi.org/10.1007/s11051-019-4681-4 . .